For the quarter ending 2026-03-31, CRMD has $815,637,000 in assets. $378,588,000 in debts. $178,087,000 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid research and development expenses | - | - | - | 123,116 |
| Cash and cash equivalents | 178,087,000 | 144,837,000 | 48,493,076 | 159,308,966 |
| Short-term investments | 0 | 3,694,000 | 7,223,735 | 31,402,850 |
| Account receivables, net | 154,807,000 | 171,233,000 | 158,574,116 | 42,911,634 |
| Inventories | 30,731,000 | 29,716,000 | 28,916,616 | 9,634,438 |
| Prepaid expenses and other current assets (including restricted cash of 656 and 656 at march31, 2026, and december31, 2025) | 19,488,000 | 17,571,000 | 16,327,730 | 4,675,885 |
| Total current assets | 383,113,000 | 367,051,000 | 259,535,273 | 248,056,889 |
| Restricted cash, long-term | - | - | - | 105,084 |
| Property and equipment, net | 6,166,000 | 5,959,000 | 4,347,360 | 1,641,152 |
| Other long-term assets (including restricted cash of 332 and 332 at march31, 2026, and december31, 2025) | 24,272,000 | 23,816,000 | 22,913,753 | - |
| Goodwill | 30,002,000 | 30,002,000 | 17,515,265 | - |
| Other assets | - | - | - | 642,066 |
| Operating lease right-of-use assets, net | - | 3,020,000 | 3,173,567 | 413,652 |
| Intangible asset, net | 368,772,000 | 379,072,000 | 390,011,711 | 1,740,260 |
| Finance lease- right-of-use assets, net | - | 946,000 | 864,549 | - |
| Deferred tax assets | 3,312,000 | 16,276,000 | 52,500,000 | - |
| Total assets | 815,637,000 | 826,142,000 | 750,861,478 | 252,599,103 |
| Operating lease liabilities, short-term | - | 853,000 | 844,431 | 177,172 |
| Accounts payable | 12,827,000 | 7,884,000 | 20,454,367 | 5,815,366 |
| Accrued expenses and other liabilities | 112,773,000 | 161,921,000 | 109,091,898 | 25,718,305 |
| Financing lease liability, short-term | - | 596,000 | 579,168 | - |
| Contingent consideration, short-term | 3,176,000 | 3,015,000 | 2,673,933 | - |
| Total current liabilities | 128,776,000 | 174,269,000 | 133,643,797 | 31,710,843 |
| Convertible senior notes, net of deferred financing costs | 144,885,000 | 144,626,000 | 144,528,552 | - |
| Contingent consideration, net of current portion | 102,397,000 | 99,101,000 | 95,591,067 | - |
| Operating lease liabilities, net of current | - | 2,253,000 | 2,411,243 | 258,073 |
| Finance lease liabilities, net of current | - | 586,000 | 557,413 | - |
| Other long-term liabilities | 2,530,000 | - | - | - |
| Total liabilities | 378,588,000 | 420,835,000 | 376,732,072 | 31,968,916 |
| Preferred stock - 0.001 par value 2,000,000 shares authorized 91,623 and 136,623 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | - | - | 92 | 92 |
| Common stock - 0.001 par value 160,000,000 shares authorized 78,395,299 and 79,260,667 shares issued and outstanding at march31, 2026 and december31, 2025, respectively | 78,000 | 79,000 | 78,350 | 74,621 |
| Accumulated other comprehensive income | 2,000 | 3,000 | 87,640 | 79,435 |
| Additional paid-in capital | 574,943,000 | 581,800,000 | 564,558,498 | 519,634,193 |
| Accumulated deficit | -137,974,000 | -176,575,000 | -190,595,174 | -299,158,154 |
| Total stockholders equity | 437,049,000 | 405,307,000 | 374,129,406 | 220,630,187 |
| Total liabilities and stockholders equity | 815,637,000 | 826,142,000 | 750,861,478 | 252,599,103 |
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)